This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Karelis, A. D. Articles by Poehlman, E. T. Search for Related Content PubMed PubMed Citation Articles by Karelis, A. D. Articles by Poehlman, E. T.

Metabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know?

Département de Nutrition, Unité Métabolique, Université de Montréal, Montréal, Québec, Canada H3T 1A8

Address all correspondence and requests for reprints to: Dr. Antony D. Karelis, Unité Métabolique, Département de Nutrition, Université de Montréal, 2405 Chemin Cote Ste-Catherine, Pavillon Liliane de Stewart, Montréal, Québec, Canada H3T 1A8. E-mail: antony.karelis{at}umontreal.ca.

Obesity is thought to be a heterogeneous disorder with several possible etiologies; therefore, by examining subtypes of obesity we attempt to understand obesity’s heterogeneous nature. The purpose of this review was to investigate the roles of metabolic, body composition, and cardiovascular disease risk in subtypes of obesity. We briefly consider two subtypes of obesity that have been identified in the literature. One subset of individuals, termed the metabolically healthy, but obese (MHO), despite having large amounts of fat mass compared with at risk obese individuals shows a normal metabolic profile, but remarkably normal to high levels of insulin sensitivity. Preliminary evidence suggests that this could be due at least in part to lower visceral fat levels and earlier onset of obesity. A second subset, termed the metabolically obese, but normal weight (MONW), present with normal body mass index, but have significant risk factors for diabetes, metabolic syndrome, and cardiovascular disease, which could be due to higher fat mass and plasma triglycerides as well as higher visceral fat and liver content. We also briefly consider the potential role of adipose and gastrointestinal hormonal profiles in MHO and MONW individuals, which could lead to a better understanding of potential factors that may regulate their body composition. This information will eventually be invaluable in helping us understand factors that predispose to or protect obese individuals from metabolic and cardiovascular disease. Collectively, a greater understanding of the MHO and MONW individual has important implications for therapeutic decision making, the characterization of subjects in research protocols, and medical education.

This work was supported by grants from the Canadian Institutes of Health Research and the Canadian Foundation of Innovation.

Abbreviations: BMI, Body mass index; GI, gastrointestinal; HDL, high density lipoprotein; MHO, metabolically healthy, but obese; MONW, metabolically obese, but normal weight.

This article has been cited by other articles:

				R. MacLaren, W. Cui, S. Simard, and K. Cianflone Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue J. Lipid Res., February 1, 2008; 49(2): 308 - 323. [Abstract] [Full Text] [PDF]

				M. A. Marini, E. Succurro, S. Frontoni, M. L. Hribal, F. Andreozzi, R. Lauro, F. Perticone, and G. Sesti Metabolically Healthy but Obese Women Have an Intermediate Cardiovascular Risk Profile Between Healthy Nonobese Women and Obese Insulin-Resistant Women Diabetes Care, August 1, 2007; 30(8): 2145 - 2147. [Full Text] [PDF]

				E. Carmina, S. Bucchieri, A. Esposito, A. Del Puente, P. Mansueto, F. Orio, G. Di Fede, and G. Rini Abdominal Fat Quantity and Distribution in Women with Polycystic Ovary Syndrome and Extent of Its Relation to Insulin Resistance J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2500 - 2505. [Abstract] [Full Text] [PDF]

				A. Yao-Borengasser, V. Varma, A. M. Bodles, N. Rasouli, B. Phanavanh, M.-J. Lee, T. Starks, L. M. Kern, H. J. Spencer III, A. A. Rashidi, et al. Retinol Binding Protein 4 Expression in Humans: Relationship to Insulin Resistance, Inflammation, and Response to Pioglitazone J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2590 - 2597. [Abstract] [Full Text] [PDF]

				J. B. Flowers, A. T. Oler, S. T. Nadler, Y. Choi, K. L. Schueler, B. S. Yandell, C. M. Kendziorski, and A. D. Attie Abdominal obesity in BTBR male mice is associated with peripheral but not hepatic insulin resistance Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E936 - E945. [Abstract] [Full Text] [PDF]

				J. Lee, S. Ma, D. Heng, C.-E. Tan, S.-K. Chew, K. Hughes, and E-S. Tai Should Central Obesity Be an Optional or Essential Component of the Metabolic Syndrome?: Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study Diabetes Care, February 1, 2007; 30(2): 343 - 347. [Abstract] [Full Text] [PDF]

				A. De Lorenzo, V. Del Gobbo, M. G. Premrov, M. Bigioni, F. Galvano, and L. Di Renzo Normal-weight obese syndrome: early inflammation? Am. J. Clinical Nutrition, January 1, 2007; 85(1): 40 - 45. [Abstract] [Full Text] [PDF]

				D. H. St-Pierre, A. D. Karelis, L. Coderre, F. Malita, J. Fontaine, D. Mignault, M. Brochu, J.-P. Bastard, K. Cianflone, E. Doucet, et al. Association of Acylated and Nonacylated Ghrelin with Insulin Sensitivity in Overweight and Obese Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 264 - 269. [Abstract] [Full Text] [PDF]

				A. Katsuki, M. Suematsu, E. C. Gabazza, S. Murashima, K. Nakatani, K. Togashi, Y. Yano, and Y. Sumida Decreased High-Molecular Weight Adiponectin-to-Total Adiponectin Ratio in Sera Is Associated With Insulin Resistance in Japanese Metabolically Obese, Normal-Weight Men With Normal Glucose Tolerance Diabetes Care, October 1, 2006; 29(10): 2327 - 2328. [Full Text] [PDF]

				A. Yao-Borengasser, N. Rasouli, V. Varma, L. M. Miles, B. Phanavanh, T. N. Starks, J. Phan, H. J. Spencer III, R. E. McGehee Jr., K. Reue, et al. Lipin Expression Is Attenuated in Adipose Tissue of Insulin-Resistant Human Subjects and Increases With Peroxisome Proliferator-Activated Receptor {gamma} Activation. Diabetes, October 1, 2006; 55(10): 2811 - 2818. [Abstract] [Full Text] [PDF]

				D. R. Garrel, R. Rabasa-Lhoret, and P. Boyle Preventing scientific fraud. Ann Intern Med, September 19, 2006; 145(6): 473 - 473. [Full Text] [PDF]

				J. B. Meigs, P. W. F. Wilson, C. S. Fox, R. S. Vasan, D. M. Nathan, L. M. Sullivan, and R. B. D'Agostino Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2906 - 2912. [Abstract] [Full Text] [PDF]

				A. D. Karelis, M. Faraj, J.-P. Bastard, D. H. St-Pierre, M. Brochu, D. Prud'homme, and R. Rabasa-Lhoret The Metabolically Healthy but Obese Individual Presents a Favorable Inflammation Profile J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4145 - 4150. [Abstract] [Full Text] [PDF]

				A. H. Berg and P. E. Scherer Adipose Tissue, Inflammation, and Cardiovascular Disease Circ. Res., May 13, 2005; 96(9): 939 - 949. [Abstract] [Full Text] [PDF]

				P. W. Speiser, M. C. J. Rudolf, H. Anhalt, C. Camacho-Hubner, F. Chiarelli, A. Eliakim, M. Freemark, A. Gruters, E. Hershkovitz, L. Iughetti, et al. Childhood Obesity J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1871 - 1887. [Abstract] [Full Text] [PDF]

				P. T. Katzmarzyk, T. S. Church, I. Janssen, R. Ross, and S. N. Blair Metabolic Syndrome, Obesity, and Mortality: Impact of cardiorespiratory fitness Diabetes Care, February 1, 2005; 28(2): 391 - 397. [Abstract] [Full Text] [PDF]